Being involved in the DNA demethylation process, TET2 facilitates the suppression of IL-6 and IL-1β, inflammatory mediators implicated in the pathogenesis of atherosclerosis (Libby and Ebert, 2018; Cong et al., 2021). Here, TET2 is linked to atherosclerosis.